• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

MI-538

CAS No. 1857417-10-7

MI-538 ( MI538 | MI 538 )

产品货号. M12867 CAS No. 1857417-10-7

MI-538 是有效的选择性 menin-MLL 相互作用抑制剂 (IC50=21 nM)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1920 有现货
10MG ¥3378 有现货
25MG ¥5646 有现货
50MG ¥8035 有现货
100MG ¥10773 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    MI-538
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    MI-538 是有效的选择性 menin-MLL 相互作用抑制剂 (IC50=21 nM)。
  • 产品描述
    MI-538 is potent and selective menin–MLL interaction inhibitor (IC50=21 nM); shows the most potent binding affinity to menin (Kd = 6.5 nM) obtained for small molecule menin–MLL inhibitor reported to date; exhibits significantly increased activity, selectivity, polarity and pharmacokinetic profile over MI-136 and demonstrates a pronounced effect in a mouse model of MLL leukemia.
  • 体外实验
    MI-538 inhibits the proliferation of MLL leukemia cells with a GI50 of 83 nM. MI-538 shows no effect (up to 6 μM) on growth of the control cell lines HL-60 and HM-2, which do not harbor MLL translocations, demonstrating good selectivity toward MLL fusion protein transformed cells. MI-538 binds to menin with low nanomolar affinity (Kd=6.5 nM). Its potent cellular activity originates from the improved binding affinity to menin and possibly increased cell membrane permeability. Treatment with MI-538 results in strong down regulation of expression of Hoxa9 and Meis1 genes. About 100 nM 27 was sufficient to reduce by ~50% Hoxa9 expression in MLL-AF9 cells, and even more pronounced effect was seen on Meis1 expression.
  • 体内实验
    Treatment with MI-538 results in a pronounced, about 80%, reduction in the MV4;11 tumor volume, without causing substantial signs of toxicity reflected by less than 10% reduction of the body weight. MI-538 demonstrates markedly improved exposure (area under the curve, AUC, values), Cmax (maximum compound concentration) in the blood plasma, and the lowest value of clearance. The half-life of MI-538 is about 1.6 h. MI-538 has also high oral bioavailability (~50%).
  • 同义词
    MI538 | MI 538
  • 通路
    Chromatin/Epigenetic
  • 靶点
    HMTase
  • 受体
    HMTase
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    1857417-10-7
  • 分子量
    566.6006
  • 分子式
    C27H25F3N8OS
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO; Need ultrasonic and warming
  • SMILES
    N#CC(N1CC2=CNN=C2)=CC3=C1C=C(O)C(CN4CCC(NC5=C(C=C(CC(F)(F)F)S6)C6=NC=N5)CC4)=C3
  • 化学全称
    1H-Indole-2-carbonitrile, 6-hydroxy-1-(1H-pyrazol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Borkin D, et al. J Med Chem. 2016 Feb 11;59(3):892-913.
产品手册
关联产品
  • GSK503

    GSK503 是一种有效的、特异性的 EZH2 甲基转移酶抑制剂,可抑制 WT 和突变型 EZH2 的甲基转移酶活性,具有相似的效力 (Ki app=3-27 nM)。

  • EPZ-015866

    EPZ-015866 (GSK-591, GSK-3203591) 是一种有效的选择性蛋白甲基转移酶 5 (PRMT5) 抑制剂,IC50 为 4 nM。

  • BAY-6035

    BAY-6035 是一种有效的组蛋白甲基转移酶 SMYD3 肽竞争性抑制剂。